Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5283286
Max Phase: Preclinical
Molecular Formula: C17H20N4O5S
Molecular Weight: 392.44
Associated Items:
ID: ALA5283286
Max Phase: Preclinical
Molecular Formula: C17H20N4O5S
Molecular Weight: 392.44
Associated Items:
Canonical SMILES: COc1ccc(S(=O)(=O)N2CCN(c3cccnc3)CC2C(=O)NO)cc1
Standard InChI: InChI=1S/C17H20N4O5S/c1-26-14-4-6-15(7-5-14)27(24,25)21-10-9-20(12-16(21)17(22)19-23)13-3-2-8-18-11-13/h2-8,11,16,23H,9-10,12H2,1H3,(H,19,22)
Standard InChI Key: LHPNKVRYCBRQPZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 392.44 | Molecular Weight (Monoisotopic): 392.1154 | AlogP: 0.48 | #Rotatable Bonds: 5 |
Polar Surface Area: 112.07 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.70 | CX Basic pKa: 5.57 | CX LogP: 0.27 | CX LogD: 0.24 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.56 | Np Likeness Score: -1.64 |
1. Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T.. (2020) Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview., 194 [PMID:32224379] [10.1016/j.ejmech.2020.112260] |
Source(1):